We are live on ! Find out more
HA

Huntleigh Advisors Portfolio holdings

AUM $585M
1-Year Est. Return 50.58%
This Fund
S&P 500
This Quarter Est. Return
+20.81%
1 Year Est. Return
+50.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$518M
AUM Growth
+$91M
Cap. Flow
+$24.4M
Cap. Flow %
4.7%
Top 10 Hldgs %
35.26%
Holding
287
New
28
Increased
139
Reduced
73
Closed
17

Top Sells

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.21M
2
XOM icon
ExxonMobil
XOM
+$2.61M
3
TXN icon
Texas Instruments
TXN
+$2.47M
4
NVDA icon
NVIDIA
NVDA
+$2.15M
5
SGOV icon
iShares 0-3 Month Treasury Bond ETF
SGOV
+$1.86M

Sector Composition

Rank Sector Weight
1 Technology 35%
2 Financials 8.77%
3 Industrials 7.93%
4 Consumer Discretionary 6.95%
5 Healthcare 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARM icon
126
Arm
ARM
$278B
$707K 0.14%
4,370
-60
-1% -$7.45K
ENSG icon
127
The Ensign Group
ENSG
$10.1B
$705K 0.14%
4,568
+244
+6% +$34.2K
CVCO icon
128
Cavco Industries
CVCO
$4.39B
$672K 0.13%
1,548
+81
+6% +$38K
MDT icon
129
Medtronic
MDT
$107B
$649K 0.13%
7,446
+2
+0% +$170
NRG icon
130
NRG Energy
NRG
$29.8B
$622K 0.12%
3,874
-100
-3% -$13.2K
HUN icon
131
Huntsman Corp
HUN
$2.24B
$615K 0.12%
+59,043
New +$719K
AMPX icon
132
Amprius Technologies
AMPX
$1.31B
$614K 0.12%
+145,914
New +$410K
XGN icon
133
Exagen
XGN
$113M
$613K 0.12%
87,861
+4,753
+6% +$28.9K
KMI icon
134
Kinder Morgan
KMI
$73.1B
$611K 0.12%
20,790
+44
+0.2% +$1.21K
NEM icon
135
Newmont
NEM
$98.2B
$610K 0.12%
10,470
-500
-5% -$26.7K
SOXQ icon
136
Invesco PHLX Semiconductor ETF
SOXQ
$2.38B
$599K 0.12%
13,730
+31
+0.2% +$1.13K
BWXT icon
137
BWX Technologies
BWXT
$16B
$598K 0.12%
4,152
+310
+8% +$36.2K
ISRG icon
138
Intuitive Surgical
ISRG
$121B
$593K 0.11%
1,091
+96
+10% +$50.2K
VCYT icon
139
Veracyte
VCYT
$4.52B
$590K 0.11%
21,809
+876
+4% +$25.4K
CSCO icon
140
Cisco
CSCO
$450B
$585K 0.11%
8,428
+55
+0.7% +$3.38K
QQQX icon
141
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.44B
$579K 0.11%
21,869
+690
+3% +$16.8K
FTC icon
142
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.31B
$570K 0.11%
3,775
-10
-0.3% -$1.38K
LSF icon
143
Laird Superfood
LSF
$46.2M
$570K 0.11%
90,432
+4,831
+6% +$30K
CALX icon
144
Calix
CALX
$2.27B
$552K 0.11%
10,383
+561
+6% +$24K
PRU icon
145
Prudential Financial
PRU
$41.7B
$538K 0.1%
5,012
-218
-4% -$22.6K
SPY icon
146
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$538K 0.1%
870
-272
-24% -$155K
BLND icon
147
Blend Labs
BLND
$409M
$536K 0.1%
162,565
+8,830
+6% +$29.9K
PG icon
148
Procter & Gamble
PG
$343B
$532K 0.1%
3,342
-20
-0.6% -$3.26K
FTCS icon
149
First Trust Capital Strength ETF
FTCS
$7.88B
$530K 0.1%
5,826
+161
+3% +$14.3K
XOM icon
150
ExxonMobil
XOM
$651B
$530K 0.1%
4,912
-24,376
-83% -$2.61M

Similar funds

Huntleigh Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Huntleigh Advisors held 287 positions worth $518M, up 21% from $427M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Huntleigh Advisors deployed $24.4M of net new capital in Q2 2025, opening 28 new positions and adding to 139 existing holdings. Its largest new stake was Fidelity Low Duration Bond Factor ETF: 166,044 shares worth $8.31M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $2.61M trimmed.

  • Huntleigh Advisors's largest Q2 2025 buy was Fidelity Low Duration Bond Factor ETF: 166,044 shares worth $8.31M.
  • Huntleigh Advisors added most to UnitedHealth in Q2 2025, an estimated $2.55M increase.
  • Huntleigh Advisors's biggest Q2 2025 reduction was ExxonMobil, cutting an estimated $2.61M.
  • Huntleigh Advisors fully exited Zoetis in Q2 2025, selling an estimated $3.21M.
  • Huntleigh Advisors's ten largest holdings make up 35% of its $518M portfolio in Q2 2025.
  • Huntleigh Advisors opened 28 new positions and closed 17 in Q2 2025.
  • Huntleigh Advisors's portfolio value rose 21% quarter-over-quarter to $518M.

Based on Huntleigh Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.